<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>Featured Headlines Feed for ENMD</title>
    <link />
    <description>Headlines for ENTREMED, INC.</description>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <generator>Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic</generator>
    <item>
      <title>New Stock Coverage: Ameriprise Turns Tommy Lee Jones Into Fat Cat</title>
      <link>http://www.fool.com/news/xt/nasdaq/www.nasdaq.com/article/new-stock-coverage-ameriprise-turns-tommy-lee-jones-into-fat-cat-cm238635.aspx</link>
      <author>Nasdaq</author>
      <pubDate>Fri, 19 Apr 2013 09:20:00 GMT</pubDate>
    </item>
    <item>
      <title>China Biotech In Review: WuXi PharmaTech Reports Another Year Of Steadily Increasing Growth</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1260701-china-biotech-in-review-wuxi-pharmatech-reports-another-year-of-steadily-increasing-growth.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 10 Mar 2013 01:22:14 GMT</pubDate>
    </item>
    <item>
      <title>Morning Market Losers</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/02/3322257/morning-market-losers.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 11 Feb 2013 10:14:07 GMT</pubDate>
    </item>
    <item>
      <title>3 Small-Cap Biotechs Possessing Zero Debt And Long-Term Potential</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1146271-3-small-cap-biotechs-possessing-zero-debt-and-long-term-potential.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Thu, 31 Jan 2013 08:47:43 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Small Cap Movers for Wednesday January 23, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/01/3268838/benzingas-small-cap-movers-for-wednesday-january-23-2013.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 23 Jan 2013 22:39:43 GMT</pubDate>
    </item>
    <item>
      <title>EntreMed Initiates Phase 2 Trial In Advanced/Metastatic Soft Tissue Sarcoma</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/01/3265615/entremed-initiates-phase-2-trial-in-advancedmetastatic-soft-tissue-sarco.aspx</link>
      <author>Benzinga</author>
      <pubDate>Wed, 23 Jan 2013 07:08:54 GMT</pubDate>
    </item>
    <item>
      <title>China Biotech In Review: China's Joinn Labs Buys Major Biopharma Campus In San Francisco</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1108811-china-biotech-in-review-china-s-joinn-labs-buys-major-biopharma-campus-in-san-francisco.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 13 Jan 2013 06:17:40 GMT</pubDate>
    </item>
    <item>
      <title>Benzinga's Small Cap Movers for Monday January 7, 2013</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/trading-ideas/long-ideas/13/01/3221920/benzingas-small-cap-movers-for-monday-january-7-2013.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 07 Jan 2013 20:51:03 GMT</pubDate>
    </item>
    <item>
      <title>EntreMed Files New Drug Clinical Trial Application for ENMD-2076 in China</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3218585/entremed-files-new-drug-clinical-trial-application-for-enmd-2076-in-china.aspx</link>
      <author>Benzinga</author>
      <pubDate>Mon, 07 Jan 2013 07:06:51 GMT</pubDate>
    </item>
    <item>
      <title>EntreMed, Inc: One Biotech Making Considerable Strides When It Comes To Breast Cancer</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1096391-entremed-inc-one-biotech-making-considerable-strides-when-it-comes-to-breast-cancer.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 06 Jan 2013 02:34:58 GMT</pubDate>
    </item>
    <item>
      <title>EntreMed Initiates Second Site For Phase 2 Trial In Triple-Negative Breast Cancer</title>
      <link>http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/01/3214928/entremed-initiates-second-site-for-phase-2-trial-in-triple-negative-breast-cancer.aspx</link>
      <author>Benzinga</author>
      <pubDate>Fri, 04 Jan 2013 07:15:31 GMT</pubDate>
    </item>
    <item>
      <title>24/7 Wall St. Closing Bell — November 26, 2012: Markets Open Low, Closed Mixed (MCD, YHOO, FB, BHP,</title>
      <link>http://www.fool.com/news/xt/247wallst/247wallst.com/2012/11/26/247-wall-st-closing-bell-november-26-2012-markets-open-low-closed-mixed-mcd-yhoo-fb-bhp-de-adt-rah-kcg-mmr-enmd/.aspx</link>
      <author>247wallst</author>
      <pubDate>Mon, 26 Nov 2012 16:07:46 GMT</pubDate>
    </item>
    <item>
      <title>7 Stocks Under $10 Making Big Moves Higher</title>
      <link>http://www.fool.com/news/xt/thestreet/www.stockpickr.com/7-stocks-under-10-making-big-moves-higher.html.aspx?puc=aol&amp;cm_ven=aol</link>
      <author>TheStreet</author>
      <pubDate>Thu, 05 Jul 2012 00:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Stock Downgrades: Bank of Ireland Struggles to Stay in Green</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/trading-and-investing/stocks/articles/upgrades-downgrades-initiations-stock-market-analyst/5/18/2012/id/41102.aspx</link>
      <author>Minyanville</author>
      <pubDate>Fri, 18 May 2012 09:30:00 GMT</pubDate>
    </item>
    <item>
      <title>10 Biotechs Targeting Cancer Stem Cell Destruction</title>
      <link>http://www.fool.com/news/xt/minyanville/www.minyanville.com/sectors/biotech-pharma/articles/bitoech-investing-biotech-stocks-biotech-companies/3/5/2012/id/39725.aspx</link>
      <author>Minyanville</author>
      <pubDate>Mon, 05 Mar 2012 09:40:00 GMT</pubDate>
    </item>
    <item>
      <title>EntreMed: Low Share Count, Multiple Upcoming Catalysts</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/237423-entremed-low-share-count-multiple-upcoming-catalysts.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Wed, 17 Nov 2010 14:42:13 GMT</pubDate>
    </item>
    <item>
      <title>China Biotech Week in Review: Shanghai Pharma Plans $1.2 Billion IPO</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/224703-china-biotech-week-in-review-shanghai-pharma-plans-1-2-billion-ipo.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 12 Sep 2010 09:39:59 GMT</pubDate>
    </item>
    <item>
      <title>Big Pharma Looks to Biotech for Innovation</title>
      <link>http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/224656-big-pharma-looks-to-biotech-for-innovation.aspx</link>
      <author>Seeking Alpha</author>
      <pubDate>Sun, 12 Sep 2010 08:14:24 GMT</pubDate>
    </item>
    <item>
      <title>EntreMed Widens Loss in 2Q, Clinical Trials for Ovarian Cancer Progress</title>
      <link>http://www.fool.com/news/xt/foxbusiness/www.foxbusiness.com/markets/2010/08/16/entremed-widens-loss-q-clinical-trials-ovarian-cancer-patients-progresses/.aspx</link>
      <author>Fox Business</author>
      <pubDate>Mon, 16 Aug 2010 12:25:50 GMT</pubDate>
    </item>
  </channel>
</rss>
